Dušan Škrbić, MD, PhD
SpecializationInternal Medicine
SubpecializationPulmonology
Head of Cystic Fibrosis Treatment Unit
Graduated from the Faculty of Medicine in Novi Sad in 2002. After completing military service, I passed the professional exam in 2003. I completed my specialization in internal medicine in April 2011 at the Faculty of Medicine in Novi Sad, and I finished my subspecialty in pulmonology in 2015. At the Faculty of Medicine, University of Novi Sad, I defended my doctoral dissertation titled “Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease and Bronchiectasis” in April 2015. In the Society of Physicians of Vojvodina of the Serbian Medical Society, I obtained the title of Primarius in 2018.
Professional expertise/field
Pulmonology, bronchiectasis, chronic obstructive pulmonary disease, lower respiratory tract infections (LRTI), community-acquired pneumonia, cystic fibrosis
| Field | Year of completion | Degree | Faculty | |
|---|---|---|---|---|
| Subspecialty | Faculty of Medicine NS | 2015. | Pulmonology Specialist | |
| Specialization | Faculty of Medicine NS. | 2011. | Internal Medicine Specialist | |
| Faculty | Faculty of Medicine NS | 2002. | Doctor of Medicine | |
| Doctorate | Faculty of Medicine NS | 2015. | Doctor of Medical Sciences |
| Training name | Field | Year | Organizer |
|---|---|---|---|
| Pulmonology, Cystic Fibrosis, Lung Transplantation | 2024. | Department of Pulmonology, Semmelweis University, Budapest, Hungary |
| Period | Title | Project role |
|---|---|---|
| 2022. | Surveillance of Influenza-like Illnesses (ILI) and Acute Respiratory Infections (ARI) in the Territory of AP Vojvodina | Participant |
LKS – Medical Chamber of Serbia, Regional Medical Chamber of Vojvodina
SLD DLV – Serbian Medical Society – Society of Physicians of Vojvodina, Serbian Medical Society
RUS – Respiratory Association of Serbia
ERS – European Respiratory Society
UBS – United Bronchologists of Serbia
ELF – European Lung Foundation
EMBARC – The European Multicentre Bronchiectasis Audit and Research Collaboration
ECFS – European Cystic Fibrosis Society
McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016 Dec;4(12):969-979
Škrbic D, Trudic (Považan) A, Đurić M, Kurucin T, Hromiš S, Handnadjev M, Tušek B, Považan Đ. Antimicrobial susceptibility of bacteria isolated from adult patients with cystic fibrosis treated in the Institute for Pulmonary Disease of Vojvodina Sremska Kamenica, Serbia, 1st Adult Cystic Fibrosis International Workshop, Milano, Italy. European Respiratory Pulmonary Diseases 2019; Vol 5; issue 1; Suppl2. Abstract Book:13. pp13-14.
Škrbić D. ERS guide bronchiectasis. 7th Congress of Respiratory Medicine of Serbia with international participation. Vrnjačka Banja, 2023. Abstract Book: 21.
Skrbic D, Djuric M, Papovic J, Tusek B. COVID-19 vaccine and morbidity in the Adult Cystic Fibrosis Centre in Institute for Pulmonary Diseases of Vojvodina Sremska Kamenica, Serbia. ERJ Open Research 2023; 9: Suppl.12, 47.
Skrbic D. The management of acute exacerbation of bronchiectasis. Abstract book of Fourth Congress of the pneumophtisiologists of Republic North Macedonia with international participation 12-14.09.2019. Struga, North Macedonia. Macedonian Medical Review. Year 73 (suppl. 104), pp. 15-16.